Summary
This 8-K filing from IDEXX Laboratories, Inc. (IDXX) reports on the company's financial results for the second quarter ended June 30, 2016. The primary purpose of the filing is to furnish the press release detailing these results, which was issued on August 2, 2016. Investors should note that this information is furnished under Item 2.02 and is not considered "filed" for certain legal purposes, meaning it's a disclosure of results rather than a formal filing amendment. The filing itself doesn't contain detailed financial figures but rather points to an attached press release (Exhibit 99.1) as the source of information. Therefore, to understand the specific performance metrics, revenue figures, profitability, and any forward-looking statements or guidance provided by IDEXX for the second quarter of 2016, investors must refer to the separate press release document.
Key Highlights
- 1IDEXX Laboratories announced its financial results for the second quarter ended June 30, 2016, via a press release on August 2, 2016.
- 2The filing is primarily an informational disclosure of these quarterly results.
- 3The detailed financial performance and operational highlights are contained within the furnished press release (Exhibit 99.1).
- 4The information provided is furnished under Item 2.02 of Form 8-K and is not deemed "filed" under Section 18 of the Exchange Act.
- 5The Chief Financial Officer, Brian P. McKeon, signed the report, indicating the CFO's oversight of the financial disclosures.
- 6The filing does not contain new material agreements, executive changes, or other significant corporate events beyond the financial results announcement.